A new study identifies the potential of specific microRNAs within extracellular vesicles as a noninvasive biomarker for predicting preeclampsia. Researchers found that women with pre-eclampsia had distinct miRNA patterns in their blood, which could help detect the condition early on.
Researchers at UCLA Health Jonsson Comprehensive Cancer Center discovered that the protein IRF1 can both hinder and help the body's immune response to tumors, depending on which cells it is found in. The study suggests that targeting IRF1 could enhance cancer treatment effectiveness by boosting natural antitumor immunity.
A UCLA-led team created a machine-learning model that can accurately predict short-term CRRT survival, providing a data-driven tool for clinical decision-making. The study aims to improve patient outcomes and resource use by serving as a basis for future clinical trials.
A new study by UCLA Health reveals racial disparities in Huntington's disease diagnoses, with Black patients receiving diagnoses one year later than White patients. The study analyzed nearly 5,000 patient data points and found that these disparities may exacerbate underrepresentation of minority groups in clinical trials.
A UCLA Health study discovered that suvorexant, an insomnia medication, blocks brain receptors for hypocretin and prevents opioid addiction in mice. The drug maintains behavioral alertness at lower doses than those inducing sleep. Further studies are needed to determine its effectiveness in humans with opioid use disorder.
Dr. Sanaz Memarzadeh and her team aim to improve treatment outcomes for patients with platinum-resistant ovarian cancer using adoptive T-cell therapy and natural killer cells. They hope to identify new targets and biomarkers for effective treatments.
Researchers at UCLA Health Jonsson Comprehensive Cancer Center have received a $1.8 million grant to advance personalized cancer therapy for prostate cancer patients. They aim to predict and prevent long-term side effects from radiation treatment, improving quality of life for men diagnosed with the disease.
Research by UCLA Health confirms that Tai Chi reduces inflammation and improves anti-viral defenses in breast cancer survivors, while cognitive behavioral therapy shows greater increases in anti-viral gene transcripts. The study found significant reductions in inflammatory biomarkers among Tai Chi participants.
A new UCLA Health study found that resilient individuals have neural activity in brain regions associated with emotional regulation and better cognition. They also exhibited a healthy gut microbiome with reduced inflammation and improved gut barrier function.
A study led by UCLA Health found that emotional awareness and expression therapy (EAET) significantly reduces chronic pain among older adults compared to cognitive behavioral therapy. EAET helps patients confront and release traumatic emotions, leading to a clinically significant reduction in pain symptoms.
A new AI model has been shown to significantly improve the accuracy of diagnosing prostate cancer by 45 times compared to doctors' measurements alone. The system assists in mapping out the boundaries of cancerous tissue, reducing the risk of underestimation and enabling more precise treatment planning and effective surgical procedures.
A new study by a global consortium provides insight into how tumors evolve, shedding light on the intricate processes underlying cancer evolution. The findings define optimal algorithms to analyze tumor evolution, enhancing diagnostic accuracy and treatment planning.
A clinical trial shows that a combination of injectable naltrexone and extended-release oral bupropion reduces methamphetamine use for up to 12 weeks. The study found a significant increase in methamphetamine-negative urine tests among participants receiving the two-drug therapy.
Researchers tracked mpox cases in a surveillance network of 13 emergency departments, finding three new cases among gay and bisexual men who have sex with men. The study highlights the need for vigilance and vaccination to prevent further transmission.
A study by UCLA researchers found that one in six primary care patients reported cannabis use, with most using it for symptom management despite identifying as recreational users. The study suggests the need for routine cannabis screening in healthcare settings.
Researchers at UCLA have identified a key protein MYCT1 that enables blood stem cells to sense and interpret signals from their environment. The study's findings could lead to the development of methods to expand blood stem cells in a lab dish, making life-saving transplants more available.
A genomic study of over 5,000 veterans with advanced prostate cancer reveals significant differences in frequencies of alterations associated with race and ethnicity. Alterations in immunotherapy targets were more common in Black veterans, potentially leading to opportunities for precision-based therapy.
A study by UCLA Health Jonsson Comprehensive Cancer Center researchers found that combining experimental immunotherapy drugs with chemotherapy significantly improves progression-free survival and overall survival for patients with metastatic colorectal cancer. The median progression-free survival was 6.2 months compared to 2.1 months f...
A recent study has cataloged gene-isoform variation in the developing human brain, providing crucial insights into neurodevelopmental and psychiatric disorders. The research found thousands of isoform switches that occur during brain development, implicating previously uncharacterized RNA-binding proteins.
A UCLA Health study has unveiled the link between genetic risk of autism and observed cellular activity in the brain. Researchers analyzed post-mortem brain tissue from 66 individuals, including those with autism spectrum disorder, to identify changes in cortical cell types and transcription factor networks.
A study found distinct brain connectivity patterns in six-week-old infants at risk for developing autism spectrum disorder. These early differences predict behavior and may lead to ASD-related behaviors by altering social development.
Researchers found that repetitive practice leads to changes in working memory circuits, making them more stable and refined. The study's findings have implications for addressing memory-related disorders.
A UCLA-led study reveals that chemotherapy for early-stage breast cancer in women over 65 can lead to a significant decline in physical function. The study found that 30% of older women who received chemotherapy experienced a substantial decline, with climbing stairs and walking being the most affected activities.
Researchers at UCLA Health Jonsson Comprehensive Cancer Center have found a combination immunotherapy treatment that enhances the immune response for people with malignant gliomas. Adding an immune-boosting agent, poly-ICLC, to a personalized dendritic cell vaccine improves the immune response and activity of T cells in patients.
Researchers at UCLA Health discovered a novel, energy-efficient mechanism of working memory that reduces metabolic cost even during sleep. The discovery is published in Nature Communications and may provide an early diagnostic for Alzheimer's disease and related dementia.
Research suggests that four proposed AI search engines for automating search and retrieval of digital histopathology slides have inadequate performance for routine clinical care. The algorithms showed less than 50% accuracy in some cases, highlighting the need for rigorous external validations and standardization before clinical adoption.
A machine learning tool called PheNet can identify patients with rare, undiagnosed diseases years earlier, improving outcomes and reducing cost and morbidity. By analyzing patterns in electronic health records, the tool ranks patients by likelihood of having a disorder like common variable immunodeficiency.
Researchers at UCLA Health have developed a potential biomarker for stroke risk using a network of inflammatory molecules in the blood. The study, published in the journal Stroke, found that patients with higher concentrations of these molecules had an 84% chance of experiencing a stroke during their lifetime.
The US Preventive Services Task Force recommends biennial breast cancer screenings starting at age 40 for all women, aiming to enhance early detection and tackle disparities. However, challenges remain in ensuring equitable access to screening technologies and addressing gaps in evidence regarding AI-powered image interpretation.
A new UCLA Health study found that undocumented Latinx patients who sought care in emergency rooms during the pandemic received the COVID-19 vaccine at the same rate as U.S. citizens. The group had higher rates of prior COVID-19 infection compared to other groups.
A new study found that genetic variants in lysosomal genes may contribute to the development of Parkinson's disease in individuals exposed to high levels of pesticides. The research suggests a potential gene-environment interaction, where minor changes in these genes can lead to increased disease risk under stress.
The FDA has approved the use of N-803, an immunotherapy drug, in combination with BCG for treating patients with non-muscle invasive bladder cancer who did not respond to conventional treatment. The approval is based on a trial led by UCLA's Dr. Karim Chamie, which showed improved outcomes and longer overall survival rates.
Research suggests that female physicians have a clinically significant impact on patient outcomes, with lower mortality and readmission rates compared to male doctors. Female patients benefit more significantly from treatment by female physicians, possibly due to better communication and understanding of sensitive health issues.
A new study by UCLA Health found that middle-aged Black Americans had the highest mortality rates from suicide, drug overdose, and alcoholic liver disease in 2022. Native Americans had the highest combined death rate from these causes over nearly two decades.
Researchers identified a gene mutation associated with impaired natural killer cell function, leading to increased susceptibility to viral infections in people with a rare genetic condition. Oleic acid supplementation shows promise as a potential therapy for these patients.
A pilot study by UCLA Health investigators suggests that treating patients with immunotherapy and chemotherapy before surgery may improve long-term outcomes for those with borderline resectable pancreatic cancer. The study found a higher rate of successful tumor removal and increased overall survival when compared to historical controls.
A new study found that lonely women exhibit increased activity in brain regions associated with food cravings and motivation towards eating high-calorie foods. The researchers also discovered a link between social isolation, obesity, and poor mental health, highlighting the importance of holistic interventions to break the cycle.
Research highlights gaps in information, support, and resources for women with serious mental illness who are pregnant or planning a pregnancy. The study found that few women recalled discussions of pregnancy with their mental health providers and were dissatisfied with the information they received about potential safety concerns.
A new therapy combines gene-modified dendritic cells with immunotherapy to promote a stronger immune response against lung cancer. The treatment slows down tumor growth and activates T cells to attack cancer cells systemically.
Researchers present findings on immunotherapy approaches, a potential biomarker for neuroendocrine carcinomas, and improved treatments for pancreatic cancer and melanoma. A UCLA team identified UCHL1 as a molecular indicator and therapeutic target for aggressive neuroendocrine cancers.
A new vaccine developed by UCLA researchers demonstrates high protection against melioidosis, a tropical disease that causes 89,000 fatalities annually. The vaccine was tested in mice and found effective even against a highly lethal strain of the bacteria.
Adding ribociclib to hormone therapy improves invasive disease-free survival by 90.4% at three years, distant disease-free survival by 90.8%, and recurrence-free survival by 91.7%. The study found a 25% relative reduction in recurrence rate for patients with stage 2 or 3 HR-positive, HER2-negative early breast cancer.
A combination of short-course hormonal therapy and stereotactic body radiation therapy has been shown to be safe and effective in treating metastatic prostate cancer. In a preliminary study, 50% of patients remained recurrence-free six months after treatment, with less than a quarter experiencing severe side effects.
Researchers found that adding a note to play up psychological sense of ownership was more effective at convincing people to get the booster. This approach outperformed lab findings and expert insights, highlighting the importance of reproducibility in behavioral science.
A study published in Journal of Psychosomatic Research suggests that short-term biofeedback therapy can alleviate certain symptoms of long COVID, including physical and mental health issues. Participants reported significant improvements after six sessions of biofeedback therapy.
A survey of healthcare professionals and laypeople found that both groups prioritize saving the greatest number of lives possible, but differ on how to achieve this. The study aims to inform policymakers and improve resource allocation during future health crises.
A new UCLA Health study found that women and individuals who don't fit traditional norms in the emergency room environment are underrepresented due to the challenging cultural dynamics. Most medical students who pursued emergency medicine despite this hurdle indicated they needed mentorship, representation, and exposure to the specialty.
UCLA Health researchers found a group of astrocytes in the central striatum regulate neurotransmitter communication and gate perseverative behavior. The discovery may lead to potential therapies for disorders like autism, OCD, and Tourette syndrome.
A study published in Cancer Research Communications reveals a potential genetic marker associated with better survival outcomes in patients with head and neck cancer. The researchers found that the presence of a specific genetic variant and higher expression of the GAN gene product gigaxonin may contribute to improved survival rates.
A UCLA Health study suggests Kundalini yoga can improve cognitive function, memory and brain health for postmenopausal women. The study found that yoga prevented brain matter decline, reversed aging and inflammation-associated biomarkers – improvements not seen in a group who received standard memory training exercises.